Key Takeaways
- The TİTCK has released an updated “Guideline on the Procurement of Medicines from Abroad,” streamlining the process for importing essential pharmaceuticals that are not licensed or unavailable in Türkiye, to ensure patient access to necessary treatments.
- The revised guideline emphasizes maintaining continuity of care by providing detailed instructions for healthcare providers to import crucial medicines on a case-by-case basis, including provisions for urgent needs and bulk procurement during health emergencies.
- The update enhances transparency and efficiency by integrating modern digital tools, such as an electronic prescription system, and aligns with international regulatory standards to improve access to advanced medical treatments for patients in Türkiye.
The Turkish Medicines and Medical Devices Agency (TİTCK) announced the release of an updated “Guideline on the Procurement of Medicines from Abroad,” which is now officially in effect. This update follows the provisions set out in the “Regulation on the Procurement of Medicines from Abroad,” originally published on February 3, 2023, in the Official Gazette, issue no. 32093.
The revised guideline marks a significant development in Türkiye’s healthcare policy, aiming to streamline the process for importing pharmaceuticals that are either not licensed domestically or are unavailable despite having a license. The primary objective of the updated guideline is to ensure that these essential medicines, necessary for diagnosing and treating various diseases, can be procured from abroad in a manner that is medically sound, ethically justified, and legally compliant.
Ensuring Continuity of Care: Türkiye’s Updated Guidelines on Importing Medicines for Urgent Patient Needs
One of the most important aspects of this update is its emphasis on maintaining continuity of care for patients. The guideline provides detailed instructions on how healthcare providers can apply for the importation of these crucial pharmaceuticals on a case-by-case basis. This process includes requiring detailed medical reports and justifications from healthcare professionals, ensuring that each request is thoroughly evaluated and that the imported medicines are used appropriately.
Furthermore, the guideline introduces specific provisions for scenarios where there is an urgent need for medicines. In such cases, hospitals are permitted to procure medicines in bulk from international suppliers to address critical health emergencies. This is particularly vital for managing unexpected outbreaks or sudden shortages of essential medications, ensuring that healthcare facilities can respond swiftly to protect patient health.
The update also reinforces the role of the TİTCK in overseeing the entire importation process. The agency is responsible for evaluating and approving requests for medicine imports, ensuring that all imported pharmaceuticals comply with stringent international safety and efficacy standards. The guideline aligns with global regulatory practices, drawing on the guidelines established by international bodies such as the International Council for Harmonisation (ICH) and the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA).
Enhancing Access and Efficiency: Türkiye Implements Digital Tools in Updated Medicine Procurement Guidelines
To improve transparency and efficiency, the updated guideline also incorporates modern digital tools for tracking and managing applications. This includes an electronic prescription system, which simplifies the submission process and allows for real-time monitoring of the status of imported pharmaceuticals. By integrating technology, the TİTCK aims to make the process more accessible and manageable for healthcare providers.
For patients, these updates hold significant implications. The new procedures are designed to improve access to necessary treatments, especially for those with rare or complex medical conditions that cannot be adequately addressed with pharmaceuticals available in Türkiye. By facilitating the importation of such medicines, the guideline supports better health outcomes and ensures that patients in Türkiye can benefit from the latest advancements in medical science, even if those treatments are not yet available domestically.
In summary, the updated “Guideline on the Procurement of Medicines from Abroad” represents a pivotal step in Türkiye’s ongoing efforts to modernize its healthcare system and align with international best practices. It underscores the country’s commitment to providing high-quality, patient-centered healthcare, ensuring that Turkish citizens have access to the medicines they need, regardless of whether those pharmaceuticals are available domestically.
Resource: Turkish Medicines and Medical Devices Agency, September 02, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
